OrganiGram (NASDAQ:OGI) had its price objective boosted by investment analysts at Stifel Nicolaus from $4.00 to $6.00 in a research note issued on Thursday, The Fly reports. The firm presently has a “hold” rating on the stock. Stifel Nicolaus’ price objective would indicate a potential upside of 138.10% from the company’s previous close.
OGI has been the subject of a number of other research reports. Raymond James dropped their target price on OrganiGram from $6.00 to $5.00 and set an “outperform” rating for the company in a research report on Wednesday. CIBC cut OrganiGram from a “neutral” rating to a “sector underperform” rating and reduced their target price for the company from $5.00 to $3.25 in a research note on Wednesday. BMO Capital Markets raised OrganiGram from an “underperform” rating to a “market perform” rating and set a $4.00 target price on the stock in a research note on Thursday, April 8th. Cantor Fitzgerald reissued an “overweight” rating and set a $6.00 target price (up from $3.50) on shares of OrganiGram in a research note on Thursday, March 11th. They noted that the move was a valuation call. Finally, Alliance Global Partners reduced their target price on OrganiGram from $4.00 to $3.75 and set a “neutral” rating on the stock in a research note on Tuesday. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and four have given a buy rating to the stock. The stock presently has an average rating of “Hold” and an average price target of $4.41.